News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Chen Bihua
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/08/2023 |
3
| Cormorant Asset Management, LP (See below) has filed a Form 3 on GreenLight Biosciences Holdings, PBC |
04/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/13/2023 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ambrx Biopharma Inc. |
01/06/2022 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Vigil Neuroscience, Inc. |
10/20/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ventyx Biosciences, Inc. |
10/07/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Pyxis Oncology, Inc. |
09/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/28/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Icosavax, Inc. |
07/15/2021 |
3
| Chen Bihua (10% Owner) has filed a Form 3 on Erasca, Inc. |
06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/25/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Design Therapeutics, Inc. |
03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/15/2020 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on BioAtla, Inc. |
11/18/2020 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
10/29/2020 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/19/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/11/2020 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Avidity Biosciences, Inc. |
04/25/2019 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Turning Point Therapeutics, Inc. |
10/30/2018 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Axonics Modulation Technologies, Inc. |
07/18/2018 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on CONSTELLATION PHARMACEUTICALS INC |
06/20/2018 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Kezar Life Sciences, Inc. |
05/23/2018 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
11/08/2017 |
3
| Cormorant Asset Management, LLC (10% Owner) has filed a Form 3 on Apellis Pharmaceuticals, Inc. |
11/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
06/13/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|